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Cancer cell targeting and therapeutic delivery of silver 
nanoparticles by mesoporous silica nanocarriers: insights into the 
action mechanisms by quantitative proteomics
Sandra Montalvo-Quirosa,b,  Guillermo Aragoneses-Cazorlaa,  Laura Garcia-Alcaldea, 
María Vallet-Regíc,d,  Blanca Gonzálezc,d,*,  Jose L. Luque-Garciaa,*
The aim of the present work is to provide an approach to safely deliver silver nanoparticles (AgNPs) as cytotoxic agents 
into cancer cells, and to provide a deeper insight into the cellular mechanisms affected by such targeted delivery. The use 
of mesoporous silica nanoparticles (MSNs) as nanovehicles decorated with transferrin (Tf, targeting agent) provides a 
nanoplatform for the nucleation and immobilization of AgNPs (MSNs-Tf-AgNPs). We have performed the physico-chemical 
characterization of the nanosystems and evaluated their therapeutic potential using bioanalytical strategies to estimate 
the efficiency of the targeting, the degree of cellular internalization in two cell lines with different TfR expression, and the 
cytotoxic effects of the delivered AgNPs. In addition, cellular localization of the nanosystems in cells has been evaluated by 
a transmission electron microscopy analysis of ultrathin sections of Human hepatocarcinoma (HepG2) cells exposed to 
MSNs-Tf-AgNPs. The in vitro assays demonstrate that only the nanosystem functionalized with Tf is able to transport the 
AgNPs inside the cells which overexpress transferrin receptors. Therefore, this novel nanosystem is able to deliver AgNPs 
specifically to cancer cells overexpressing Tf receptors and offers the possibility of a targeted therapy using reduced doses 
of silver nanoparticles as cytotoxic agents. Then, a quantitative proteomic experiment validated through the analysis of 
gene expression has been performed to identify the action molecular mechanisms associated with the chemotherapeutic 
potential of the MSNs-Tf-AgNPs nanocarriers.
Introduction
The rise of nanoscience in biomedical applications and the 
need for targeted therapies is a challenge in the development 
of nanosystems that allows reduced doses of therapeutic 
agents as well as their specific release in targeted cells. 
Nowadays, nanoparticles are a field in increasing development 
due to its diverse applications in consumer products, 
technology, industry or medicine. These materials exhibit 
excellent properties, such as their reduced size or improved 
physico-chemical properties compared to higher scale 
materials, and have recently allowed significant advances in 
therapeutic and preventive nanomedicine.1,2
It is well known that silver nanoparticles (AgNPs) have 
different applications based on their efficient and broad-
spectrum of antibacterial activity and also exhibit plasmonic 
properties.3,4 Recently, AgNPs are also receiving considerable 
attention as potential anticancer therapeutic agents.5-7 In this 
case, it is important to point out that the use of AgNPs to 
inhibit angiogenesis or cell growth and their use in diagnosis is 
limited by their tendency to aggregate, as well as by the 
different mechanisms of toxicity that can be induced in the 
organism, since its administration could also provoke cytotoxic 
effects on healthy cells.8,9 In fact, several studies have shown 
the different effects of silver nanoparticles in cancer cell 
lines.3,10-12 Hence, the growing studies of AgNPs as therapeutic 
agents in cancer disease generates the need to avoid non-
specific delivery and toxicity in healthy cells.13 Additionally, the 
AgNPs tendency to aggregate makes it necessary to improve 
their way of transport and selective intracellular release in 
cancer cells.
On the other hand, mesoporous silica nanoparticles (MSNs) 
possess, besides its biocompatibility, key features that make 
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them versatile and very attractive for nanomedicine.14-16 MSNs 
usually show particle diameters in the 50-200 nm range and 
narrow pore size distributions of 3-6 nm. Their highly ordered 
pore network is used to store drug molecules,17,18 and their 
silanol rich surface provides covalent attachment of organic 
moieties to the MSNs to impart stealth, targeting19-21 or smart 
functionalities.22-24 Hence, several studies demonstrate their 
use in drug delivery,25-27 diagnosis28 or vaccines,29,30 among 
others.
Anticancer applications of nanoparticles are highly motivated 
by the enhanced permeability and retention (EPR) effect, 
which entails a preferential accumulation of the NPs in the 
solid tumor microenvironment, also known as passive 
targeting.31 For the active uptake, the differential 
characteristics of tumor cells, such as the over-expression of 
transferrin or folic acid receptors, allows the selective and 
specific recognition by these cells of nanomaterials presenting 
the corresponding ligands.32,33 An advantage of targeting with 
transferrin (Tf), in comparison to other signaling ligands, is its 
lack of complicated downstream signaling effects, because its 
internalization is mainly based on a nutrient uptake 
mechanism.34-36
Based on the above, immobilization of AgNPs in a supporting 
matrix together with transferrin as a cancer cell targeting 
ligand, would avoid AgNPs aggregation while maintaining the 
possibility of its selective delivery to specific cells. For this 
reason, the aim of this study is the synthesis and evaluation of 
a hybrid nanosystem consisting of metallic AgNPs well 
dispersed on the external surface of MSNs decorated with 
transferrin for cancer cell targeting. This new nanosystem 
exploits a biological entity, the transferrin protein, as 
nucleation agent to externally modify MSNs with silver 
nanoparticles and, at the same time, the transferrin protein 
works as a targeting agent in the final nanosystem. In this 
manuscript we explore the selective transport of silver 
nanoparticles to tumor cells with the aim to achieve a 
therapeutic delivery useful for anticancer therapy. The 
effectiveness of the nanosystem is confirmed by the 
development of a counterpart nanosystem with bovine serum 
albumin (BSA) as control protein. The anticancer potential of 
these nanosystems has been assayed in HepG2 and MC3T3-E1 
cell lines with clear difference in transferrin receptor (TfR) 
expression, including a TEM study of ultrathin sections of 
HepG2 cells exposed to the nanosystem. Furthermore, a 
quantitative proteomics study validated by gene expression 
analysis has been performed to evaluate the differential 
nuclear proteins expression of HepG2 cells after exposure to 
the effective nanosystem. The results lead to the identification 
of key protein targets and molecular mechanisms associated 
with the potential antitumoral properties of the designed 
nanosystem.
Experimental
Reagents and equipment
Fluorescein isothiocynate (FITC), tetraethylorthosilicate 
(TEOS), cetyltrimethylammonium bromide (CTAB), N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride 
(EDC.HCl), 2-morpholinoethanesulfonic acid (MES), bovine 
serum albumin (BSA), transferrin human (Tf), citric acid, silver 
nitrate 99.9% and water (HPLC grade) were purchased from 
Sigma-Aldrich. 3-Aminopropyltriethoxysilane 97% (APTS), 3-
(triethoxysilyl)propylsuccinic anhydride 94% (TESPSA) were 
purchased from ABCR GmbH & Co.KG. All other chemicals 
(ammonium nitrate, absolute EtOH, dry toluene, NaOH, etc.) 
were of the highest quality commercially available and used as 
received.
The analytical methods used to characterize the synthesized 
compounds were as follows: thermogravimetric and 
differential thermal analysis (TGA), chemical microanalyses, 
solid state magic angle spinning (MAS) NMR and cross 
polarization (CP) MAS NMR spectroscopy, low-angle powder X-
ray diffraction (XRD), N2 adsorption porosimetry, 
electrophoretic mobility measurements to calculate the values 
of zeta-potential (), dynamic light scattering (DLS), scanning 
electron microscopy (SEM), energy dispersive X-ray 
spectroscopy (EDS) and transmission electron microscopy 
(TEM). The equipment and conditions used are described in 
the Electronic Supplementary Information (ESI).
Materials synthesis
MSNs and MSNs-COOHext materials were synthetized as 
published,37 see details in the Electronic Supplementary 
Information (Figure SI.1).
MSNs-Protein. A starting MSNs-COOHext material with a 
nominal value of –COOH groups of 1.22  103 mol/g SiO2 was 
used for the protein anchorage. Prior to the conjugation of 
proteins, the -COOH groups on the surface of MSNs-COOHext 
were activated. For this activation, EDC·HCl (820 mg, 10 equiv 
per nominal –COOH groups) was dissolved in water and added 
to a vigorously stirred suspension of MSNs-COOHext (0.4 g) 
well dispersed in water (150 mL, HPLC grade). The mixture was 
stirred at RT for 3 h in the dark. Then, the solid was centrifuged 
and rinsed with water to remove the residuals of EDC. Then, 
activated MSNs-COOHext was re-dispersed in MES 
monohydrate (50 mM, pH depending on the protein) under 
gently stirring. After that, each protein (BSA or Tf) was 
dissolved in MES monohydrate 50 mM (pH 4.8 or pH 6, 
respectively) and added over the material suspension. The 
mixture was stirred overnight in the dark, centrifuged at 11000 
rpm for 20 min, the solid exhaustively washed with water and 
finally dried. Materials were denoted as MSNs-BSA and MSNs-
Tf, respectively.
Silver nanoparticles nucleation onto MSNs-Protein. For the 
nucleation of AgNPs, silver nitrate was used as silver ions 
source. The procedure was optimized depending on the 
reduction agent used and the isoelectric point of each protein.
MSNs-BSA-AgNPs. 5 mL of a silver nitrate solution (1 mg/mL) 
were added over a dispersion of 10 mg of MSNs-BSA in water 
and the mixture stirred 1 h at RT in the dark. After this, a 
solution of citric acid (Ag+/citric acid, 1:2) was added dropwise 
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and stirred overnight in the dark at RT. The obtained solid was 
washed with water and dried.
MSNs-Tf-AgNPs. 10 mL of a silver nitrate solution (1 mg/mL) 
were added over a dispersion of 10 mg of MSNs-Tf in HEPES 
buffer 20 mM (pH 8.2) and the mixture stirred 1 h at RT in the 
dark. After this, water was added to obtain a good dispersion 
that was stirred overnight in the dark at RT. The obtained solid 
was washed with water and dried.
In vitro cell assays
Cell culture. Human hepatocellular carcinoma cell line (HepG2) 
and mouse osteoblast-like cell line (MC3T3-E1) purchased 
from ATCC were used to evaluate internalization and 
biocompatibility of the nanomaterials. HepG2 cells were 
maintained in Dulbecco´s modified Eagle´s medium (DMEM) 
and MC3T3-E1 in alpha modified Eagle´s medium (a-MEM). 
Both culture media were supplemented with 10% fetal bovine 
serum (FBS) and 1% penicillin/streptomycin at 37 C and 5% 
CO2.
Cytotoxicity assay. For evaluating the cell viability, HepG2 cells 
were seeded on 96-well plates 24 h prior to the experiment. 
After cell attachment, they were exposed to 10, 50 and 100 
g/mL of different materials for 24, 48 and 72 h of contact 
times. Then, 20 L of 3-(4,5-dimethyl-thiazol-2-yl)2,5-diphenyl 
tetrazolium bromide (MTT, 5 mg/mL) were added to each well 
and incubated for 5 h at 37 C. Then, the MTT solution was 
removed and 100 L of dimethyl sulfoxide were added to 
dissolve the insoluble purple formazan products. The 
absorbance at a 595 nm was measured using a microplate 
reader (TECAN) and the cell viability calculated through the 
relation between the absorbance of treated-cells and the 
absorbance of control cells. 
Live-dead staining assay. For calculating the percentage of 
dead cells, HepG2 cells were seeded on 6-well plates 24 h prior 
to the experiment. After cell attachment, they were exposed 
to 10, 50 and 100 g/mL of different materials (MSNs-Tf and 
MSNs-Tf-AgNPs) for 24 h. Then, cells were harvested and 
stained with trypan blue. The percentages of live and dead 
cells were obtained using an automated cell counter (Countess 
II, Fisher Scientific).
Cell uptake assays. Two different assays were carried out to 
evaluate the cell uptake of MSN-Protein and MSNs-Tf-AgNPs 
materials. In order to confirm the preferential uptake of 
transferrin targeted-material, MC3T3-E1 and HepG2 cells were 
seeded on 6-wells plates and exposed to 100 g/mL of MSNs-
BSA and MSNs-Tf materials for 24 h. To evaluate the effect of 
metallic nanoparticles after cell uptake, several concentrations 
(10, 25, 50 g/mL) were tested for different exposure times 
(24 and 48 h). In both cases, the procedure was the following: 
after the contact time, the medium was aspirated and the cells 
were washed with PBS and harvested using a 0.25% trypsin-
EDTA solution. After 10 or 5 min, depending on the cell line, 
the reaction was stopped with culture medium and the cells 
were centrifuged at 289 g for 5 min and resuspended in PBS 
for analysis by flow cytometry. Trypan Blue (0.4%) was added 
at that time to quench the fluorescence of the MSNs adhered 
to the outside membrane of the cells. The percentage of cells 
that had internalized MSNs was quantified as the fraction of 
fluorescein positive cells among the number of total cells. 
Then, the intensity of the green fluorescence of the positive 
cells was measured.
Localization of MSNs-Tf-AgNPs inside HepG2 cells. Cells were 
exposed to MSNs-Tf-AgNPs at two concentrations (10 and 25 
g/mL) and incubated at 37 C in 5% CO2 for 24 h. Afterwards, 
the cells were harvested, rinsed with PBS and fixed with 2.5% 
glutaraldehyde and 4% p-formaldehyde in PBS for 4 h at 4 C. 
After this time, cells were washed twice with PBS and 
incubated in PBS at 4 C overnight. After incubation with 1% 
OsO4 in Milli-Q water for 1 h at RT, the samples were washed, 
dehydrated in a graded series of acetone and embedded in 
resin for 72 h at 67 C. Ultrafine sections were cut with 
ultramicrotome, deposited on copper grids, stained with 
uranyl acetate and chrome citrate and analyzed by 
transmission electron microscopy (JEOL 2100, CNME).
Quantitative proteomics
Metabolic labelling. HepG2 cells were maintained in DMEM 
medium supplemented with 10% dialyzed FBS, 100 units per 
mL of penicillin/streptomycin and either naturally-occurring 
isotope abundances (“light”) or stable isotope-labeled 
(“heavy”) 13C6 arginine and 13C6 lysine amino acids. Culture 
media were refreshed when 100% (1107 cells) plate 
confluence was reached and the cells were grown for at least 6 
doublings to allow full incorporation of the labeled amino 
acids. Six large-scale SILAC replicates (3107 cells per 
condition) were performed. The full incorporation of labeled 
amino acids was verified by MS analysis of a protein digest 
(data not shown).
Protein extraction, SDS-page and in gel digestion. After 
differential labeling, control and cells exposed to 25 g/mL 
MSN-Tf-AgNPs for 48 h were mixed in a 1:1 ratio. Nucleic acid 
binding proteins fraction was extracted by following the 
extraction protocol of Qproteome Nuclear Protein Kit 
(QIAGEN). Protein extracts were separated by SDS-PAGE on 
10% SDS-polyacrylamide gels, visualized by Coomassie blue 
staining and the gel lanes were cut horizontally into 20 
sections. Excised gel bands were de-stained firstly in 25 mM 
ammonium bicarbonate followed by a 50:50 25 mM 
ammonium bicarbonate/acetonitrile solution and then were 
dried. Gel pieces were rehydrated with 12.5 ng/L trypsin 
solution in 25 mM ammonium bicarbonate and incubated 
overnight at 37 oC. Peptides were extracted using acetonitrile 
and 5% formic acid, dried by vacuum centrifugation and 
reconstituted in 12 L 2% acetonitrile 0.1% formic acid.
Mass spectrometry analysis: protein identification and 
quantification. Peptide mixtures were analyzed using 
nanoflow LC-MS/MS (Eksigent). Peptides were loaded onto a 
0.3  10 mm C18 precolumn (SGE) and separated by a reverse-
phase column (75 m  15 cm fused silica capillary C18 HPLC 
PepMap column, 3 m, 100 Å, Thermo) with linear gradient of 
5-95% acetonitrile in 0.1% aqueous solution of formic acid. The 
samples were delivered over 120 min at a flow rate of 200 
Page 3 of 16 Nanoscale
N
an
os
ca
le
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
12
 F
eb
ru
ar
y 
20
19
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
id
ad
 A
ut
on
om
a d
e M
ad
rid
 o
n 
2/
12
/2
01
9 
2:
57
:1
3 
PM
. 
View Article Online
DOI: 10.1039/C8NR07667G
ARTICLE Nanoscale
4 | Nanoscale, 2018, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins
Please do not adjust margins
nL/min through the analytical column to a stainless steel nano-
bore emitter (Proxeon). The peptides were scanned and 
fragmented with an LTQ XL linear ion trap mass spectrometer 
(Thermo Scientific) operated in data-dependent ZoomScan and 
MS/MS switching mode using the three most intense 
precursors detected in a survey scan from 400 to 1600 u (three 
scans). ZoomScan mass window was set to 12 Da enabling 
monitoring of the entire 12C/13C isotopic envelope of double 
and triple charged peptides; single charged ions were excluded 
for MS/MS analysis. Normalized collision energy was set to 
35% and dynamic exclusion was applied during 3 min periods 
to avoid repetitive fragmentation ions. The generated .raw 
files were converted to .mgf files for MASCOT data search. A 
database containing the NCBInr Homo sapiens sequences 
containing 113620 entries (31/03/18) was searched using 
MASCOT software (version 2.3 MatrixScience) for protein 
identification. Oxidation of methionine and 13C6-Arg and 13C6-
Lys were specified as variable modifications, trypsin as the 
specific enzyme and one missed cleavage allowed. Minimum 
precursor and fragment-ion mass accuracies of 1.2 and 0.3 Da 
were used. A requirement of at least one bold (unique) red 
peptide (i.e. the highest scoring peptide matches to the 
protein with the highest total score) was required for protein 
identification and at least two bold red (unique) peptides were 
required for quantification. Cut-off values for MASCOT scores 
of peptides and proteins were set to 39 (p < 0.05) and 46 (p < 
0.01), respectively. The false positive rate was calculated by 
searching the same spectra against the NCBInr Homo sapiens 
decoy database. Relative quantitation ratios of identified 
proteins were calculated using QuiXoT (version 1.4.02). SILAC 
ratios were defined by the area of the heavy peptides (13C) 
divided by the area of light (12C). Protein ratios obtained by 
QuiXoT were manually verified for all peptides. As observed in 
previous studies, a proportion of 13C6-Arg was converted to 
13C5-Pro, leading to a reduction in the intensity of the isotope 
labeled peptide peak; this was corrected for all peptides 
containing one or more proline residues. Molecular and 
cellular functions of the proteins found to be deregulated by 
SILAC were assigned based on the biological knowledge 
available in Gene Ontology (GO) annotations.
RNA extraction and RT-PCR analysis. Total RNA was isolated 
from HepG2 cells after treatment with MSN-Tf-AgNPs (25 
µg/mL), using TRIzol reagent (Invitrogen) according to the 
manufacturer’s instructions. The quantity of extracted RNA 
was measured by Nanodrop One (Thermo Fisher Scientific). 
Synthesis of cDNA with integrated removal of genomic DNA 
contamination was performed by Quantitect reverse 
transcription kit (Quiagen) using 1 μg of RNA. RT-PCR analysis 
was carried out using TaqMan gene expression assays (Thermo 
Fisher Scientific) and TaqMan Fast advance master mix 
(Thermo Fisher Scientific) according to the manufacturer’s 
instructions. The references of TaqMan gene expression assays 
used are listed in Table 1. All reactions were performed in a 
final volume of 10 μL. The reaction protocol was 2 min at 50 
C, 10 min at 95 C for activating polymerase and 40 cycles for 
15 seconds at 95 C and 1 min at 60 C. Relative expression of 
genes was normalized using GADPH as the endogenous 
control. Gene expression in each sample was calculated as 2–
ΔΔCt.
Table 1. References of TaqMan gene expression assays used for the RT-PCR analysis.
Gene RefSeq Assay ID
RCF3 RCF3 NM_002915.3
CHERP CHERP NM_006387.5
DDX3X DDX3X NM_001193416.2
SHMT2 SHMT2 NM_001166356.1
Ciclina E CCNE1 NM_001238.3
Cdk2 CDK2 NM_001290230.1
GADPH GADPH NM_001256799.2
Scheme 1. Synthesis of hybrid MSN materials functionalized with BSA or Tf proteins 
and silver nanoparticles.
Results and discussion
Proteins grafting to mesoporous silica nanoparticles
The whole synthetic approach to obtain hybrid materials is 
shown in Scheme 1. To provide anchoring points for the 
proteins, the external surface of the MSNs was functionalized 
with carboxylic acid groups in a first step, using a post-
synthesis method.37 In a second step, amide bonds were 
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formed for the covalent anchorage of proteins to the MSNs-
COOHext material. To achieve this, some of the free primary 
amino groups on the BSA or Tf proteins, present in lysine and 
arginine amino acids, were condensed with the carboxylic acid 
groups in the external MSNs surface through carbodiimide 
chemistry. The isoelectric points of the proteins and the pH of 
the condensation reaction play an important role in the 
protein anchorage to the MSNs. Therefore, the pH of the 
reaction was fixed below the isoelectric point of the proteins 
(IEPBSA 5.87 ‡,38 and IEPTf 6.97 ‡‡,39) to avoid electrostatic 
repulsion of the negative surface of the silica nanoparticles 
(MSNs-COOHext) with the negatively charged proteins above 
the isoelectric point.40 Due to steric hindrance effects that 
occur when macromolecules are employed to functionalize the 
silica surface, the amount of protein used in these syntheses 
was previously optimized by using an excess of protein for the 
reaction. Hence, the amount of anchored protein was 
estimated from TG measurements and set up as the optimal or 
maximum amount of protein able to be anchored. The 
obtained molar relation between carboxylic acid groups to 
anchored protein (nCOOH/nProt) was 1 to 1.4  103 and it was 
then used for the rest of reactions.
Silver nanoparticles nucleation onto proteins functionalized MSNs 
materials
To obtain the hybrid materials with proteins and metallic 
nanoparticles, two synthetic routes were followed depending 
on the protein attached onto the MSNs (Scheme 1). Silver 
nitrate was the metallic ion precursor and the pH was fixed 
above the IEP of each protein in both cases. Thus, the proteins 
present residues of glutamate (Glu) and aspartate (Asp) acids 
negatively charged which must be involved in the site-specific 
localization of positive silver ions.41-43 For the nucleation of 
silver nanoparticles (AgNPs) onto MSNs-BSA, silver ions were 
allowed to be complexed first at pH 7 and, subsequently, citric 
acid was used as reducing agent carrying out the reaction in a 
slightly acid pH but higher than the isoelectric point of the 
protein (IEPBSA 5.87).44 On the other hand, a HEPES solution 
was used to nucleate AgNPs onto MSNs-Tf. The structure of 
transferrin possesses less amount of negative residues Asp and 
Glu than BSA and the isoelectric point is higher (IEPTf 6.97). For 
these reasons it was necessary a basic medium for the 
synthesis. The HEPES solution was used as buffer to set the pH 
at 8.2 during the synthesis, and also as a reducing agent, 
because it has been reported in previous studies for the 
preparation of gold and silver nanoparticles.45-48 Nevertheless, 
it is important to mention that only a small proportion of the 
carboxylic acid groups on the external surface of the MSNs 
have been used for protein attachment. Therefore, there are 
carboxylate residues also acting as nucleating sites for the Ag+ 
at the pH established for the syntheses, since carboxylic acid 
group in hydrocarbon chains with three to six carbon long have 
a pKa around 4.8.49
Materials characterization
The incorporation of the alkoxysilane derivative and the BSA or 
Tf proteins was followed by quantification of the organic 
content of the MSNs materials by TGA and elemental chemical 
analyses (Table 2). The results confirm the expected successive 
increase of the organic content after functionalization of the 
MSNs with the alkoxysilane in the first step and the proteins 
attached in the second step. Sulphur and nitrogen content in 
MSNs-BSA and MSNs-Tf samples confirm the presence of 
amino acids from the anchored proteins.
Table 2. Organic content and elemental composition from thermogravimetric and 
chemical analysis of MSNs and functionalized MSNs materials.
Material Theor. 
Org. 
(wt%)
Org. 
Content 
(wt%)
%C %N %S
MSNs - 4.53 3.64 0.05 0.03
MSNs-COOHext-CTAB - 36.27 b 30.86 1.85 0.02
MSNs-COOHext 9.73 7.81 b 10.11 0.10 0.01
MSNs-BSA 19.54 a 13.69 b 14.27 2.93 0.26
MSNs-Tf 19.55 a 13.67 b 13.94 2.86 0.26
a Theoretical organic content (wt%) is calculated without considering the loss of 
water molecules which are produced in the condensation reaction for the protein 
anchorage. b Organic content (wt%) is determined from the TGA weight losses, 
excluding the weight loss due to the desorption of water (up to 125 C) and 
further corrected by the weight loss of the remaining alkoxysilanes after the sol-
gel reaction (surfactant extracted unmodified MSNs).
Table 3. -potential values and hydrodynamic particle size in water medium of MSNs 
materials.
Material -potential (mV) a Hydrodynamic size a,b (nm)
MSNs -25 ± 8 199 ± 8
MSNs-COOHext -29 ± 5 209 ± 15
MSNs-BSA -21 ± 3 166 ± 33
MSNs-Tf -20 ± 4 166 ± 16
MSNs-BSA-AgNPs -13 ± 7 197 ± 21
MSNs-Tf-AgNPs -8 ± 3 196 ± 12
a samples were measured in quintuplicate (n = 5). b maximum of the size 
distribution measured by DLS.
Zeta-potential () values and hydrodynamic sizes were 
measured to evaluate the functionalization process (Table 3). 
The grafting of the alkoxysilane TESPSA produces a more 
negative -potential compared to the bare MSNs, due to the 
co-existence of negative-charged –SiO groups of silica in 
water plus -COO groups from the new carboxylic acid 
functionalities. The subsequent introduction of the proteins 
onto MSNs-COOHext, provokes a change towards a less 
negative -potential. These results are consistent with the fact 
that only a small proportion of the –COOH groups are 
converted into amide bonds due to the expected steric 
hindrance of the proteins. Also, in the water media the 
proteins must be above or close to their isoelectric point, i.e., 
negatively charged or close to neutral, therefore not 
influencing the final value.
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All MSNs exhibit high enough negative -potential values to be 
in the colloidal stability zone50 and dynamic light scattering 
(DLS) measurements show monomodal hydrodynamic size 
distributions between 130-250 nm for all the MSNs materials 
(See Figure SI.2 for MSNs-Tf material as a representative 
example). The maximum of the size distribution was not 
significantly altered during the alkoxysilane and protein 
grafting processes. Nevertheless, the MSNs-BSA and MSNs-Tf 
materials possess a smaller hydrodynamic size than bare MSNs 
and the functionalized MSNs-COOHext, reflecting a decrease in 
the magnitude of the aggregates of nanoparticles in water 
media. Therefore, the presence of organic macromolecules 
attached to the external surface of the MSNs in the hybrid 
materials contributes as well to a steric repulsion that 
decreases the size of the aggregates in solution.
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Figure 1. 13C {1H} CP MAS NMR spectra of materials: MSNs (A), MSNs-COOHext (B) and 
MSNs-BSA (C). Peaks designated with # correspond to ethoxy groups due to incomplete 
hydrolysis and condensation.
Figure 1 shows the 13C{1H} CP MAS NMR spectra of materials 
recorded to follow the incorporation of organic matter on the 
silica surface. The two peaks at 64 and 15 ppm, which are 
common in all the spectra, correspond to the methylene and 
methyl groups, respectively, from ethoxy groups due to 
incomplete hydrolysis and condensation of the 
tetraethylorthosilicate precursor during the sol-gel synthesis of 
MSNs.51 These ethoxy groups represent around a 5% of 
organic content in the TG analysis of extracted MSNs, which 
does not correspond to the remaining surfactant since the %N 
is negligible (see TG and AQE data in Table 2).  The spectrum of 
MSNs-COOHext (Figure 1B), shows the signals of the hydrolyzed 
propylsuccinic acid present on the hybrid material. The broad 
signal at ca. 178 ppm corresponds to the carbonyl moiety from 
carboxylic acid groups. Then, the CH adjacent to the carboxylic 
acid group shows a peak at 43 ppm (signal d) and the peak at 
37 ppm corresponds to the sum of CH2 groups close to the 
carboxylic acid group (signal c and e). The peak at 21 ppm 
matches with the methylene carbon in the chain (signal b) and, 
finally, methylene carbon directly attached to silicon atom 
shows a peak at 13 ppm (signal a).  As a representative 
example for both proteins, Figure 1C shows the spectrum of 
MSNs-BSA which confirms the covalent attachment of BSA 
protein to the carboxylic acid groups on the surface of MSNs-
COOHext. Chemical shifts in this spectrum are coincident with 
those of the respective BSA protein in the solution NMR 
spectrum of the free protein (see Figure SI.3 in ESI). The 
carbonyl signal at ca. 178 ppm is broadened with respect to 
the MSNs-COOHext material due to the presence of carbonyl 
groups of carboxylic acids and amide bonds in the protein 
structure itself. However, a more intense signal shows up at 
158 ppm supporting the formation of amide bonds between 
the –COOH from TESPSA and –NH2 from some lysine and 
arginine amino acids of the protein.
Figure 2. 29Si MAS NMR spectra (left) and 29Si CP MAS NMR spectra (right) of MSNs, 
MSNs-COOHext and MSNs-BSA materials.
Solid state 29Si MAS NMR spectroscopy was used to further 
analyze the functionalization of mesoporous silica 
nanoparticles. Figure 2 (left) compares the quantitative spectra 
from the direct polarization method obtained for the bare 
MSNs material with those obtained for the functionalized 
materials MSNs-COOHext and MSNs-BSA. In addition, 29Si CP 
MAS NMR spectra were also registered (Figure 2, right) to 
assess the existence of T units [R-Si(OSi)n(OX)3n] (X = H, C). 
This method uses cross-polarization from the nearby protons 
and yields unquantitative experiments, but confirms the 
presence of the functionalizing trialkoxysilane in the materials. 
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Table 4. Chemical shifts and populations (%) of the silicon Qn and Tn environments and peak area relations, (Q2 + Q3)/Q4 and Qn/Tn units, on the basis of the 
deconvolution of 29Si MAS NMR spectra of MSNs materials.
δ, ppm (peak area, %) δ (ppm) peak areaMaterial
Q2 Q3 Q4 (Q2 + Q3)/Q4 T2 T3 Q/T
MSNs -93.2  (6.2) -102.3  (44.6) -112.0  (49.1) 1.0 --- --- ---
MSNs-COOHext -93.6  (3.2) -102.7  (36.5) -112.0  (60.2) 0.6 -57.8 -66.9 15.3
MSNs-BSA -92.5  (3.7) -102.8  (32.1) -112.5  (64.0) 0.5 -58.3 -66.4 15.7
B
200 nm 
C
100 nm 
E
200 nm 
F
100 nm 
A
H
I
Ag
Si
D
50 nm 
G
50 nm 
Figure 3. TEM images of the materials: MSNs (A), MSNs-BSA-AgNPs (B, C and D) and MSNs-Tf-AgNPs (E, F, G and H). EDX analysis of MSNs-Tf-AgNPs (I).
Therefore, T2 [R-Si(OSi)2(OX)] and T3 [R-Si(OSi)3] units show 
signals at 57 and 66 ppm, respectively, in the CP spectra of 
the functionalized MSNs-COOHext and MSNs-BSA materials. 
Table 4 shows the chemical shifts and populations of these 
silicon environments from the 29Si MAS NMR. All spectra 
showed three resonances at around 93, 102 and 113 ppm 
for the Q2 [Si(OSi)2(OX)2], Q3 [Si(OSi)3(OX)] and Q4 [Si(OSi)4] 
silicon sites, respectively (X = H, C). The grafting of alkoxysilane 
species on the silica surface provokes a decrease in the Q2 and 
Q3 peak areas and an increase in the Q4 population due to the 
conversion from Si-OH to fully condensed Si-O-Si species. As 
shown in Table 4, a decrease in Q2 and Q3 area peaks and an 
increase in Q4 confirm the covalent grafting of TESPSA in 
MSNs-COOHext. The relative ratio of partially to fully 
condensed silicon sites, (Q2 + Q3)/Q4, confirms that the inner 
surface of the channels was preserved from functionalization, 
since this step is performed before the surfactant extraction 
stage. These findings are also verified by the N2 sorption 
studies (see ESI and Figure SI.4).  As expected, the populations 
of Qn environments in MSNs-BSA are maintained as compared 
to the previous material, MSNs-COOHext, because the protein 
is attached through the carboxylic acid groups. The relation of 
Qn/Tn environments is also maintained when MSNs-COOHext is 
compared with MSNs-BSA, supporting the anchorage of 
proteins over carboxylic acids groups without involving silicon 
sites.
Figure 3 shows TEM micrographs of the materials at different 
magnifications (see also Figure SI.5). A well dispersion of the 
silver nanoparticles onto the surface of both MSNs-BSA-AgNPs 
(Figure 3B-D) and MSNs-Tf-AgNPs (Figure 3E-G) can be 
observed. The metallic nanoparticles present homogeneous 
sizes in both materials, which are around 15 nm for MSNs-Tf-
AgNPs (Figure 3H) and smaller for the MSNs-BSA-AgNPs. In 
addition, free AgNPs away from the MSNs surface were not 
found in the TEM analysis, indicating that the nucleation and 
growth of the AgNPs takes place on the outer MSNs surface 
covalently functionalized with the proteins. These results are 
also verified by DLS measurements of the hydrodynamic size of 
the materials (Table 3) where only a population around 196 
nm was found, corresponding to the whole nanosystem 
(MSNs-Protein-AgNPs). Moreover, the absence of a 
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population around 20 nm indicates that in water suspension 
the AgNPs are not released from the protein modified-
mesoporous silica nanosystem. AgNPs containing nanosystems 
have the maximum of the hydrodynamic size distribution 
shifted towards a slightly higher value than the corresponding 
MSNs-Protein materials. This effect is probably due because 
the MSNs-Protein-AgNPs present a -potential value less 
negative than the formers, i.e., away from the zone of colloidal 
stability.
The atomic percentages for silver and silicon were measured 
by EDS analysis registered at low magnifications of AgNPs 
containing materials, finding 0.40% Ag and 99.60% Si for 
MSNs-BSA-AgNPs and 0.53% Ag and 99.47% Si for MSNs-Tf-
AgNPs. These values represent a 0.004 molar ratio of Ag/Si for 
the MSNs-BSA-AgNPs material and 0.005 Ag/Si molar ratio for 
MSNs-Tf-AgNPs material, thus being comparable and 
representing a similar content in silver in both materials, 
independent of the attached protein. These results also 
support the participation of the carboxylic acid groups on the 
MSN-Protein silica external surface in the localization of silver 
cations besides the protein itself for their subsequent 
reduction and nucleation, as discussed above.
In addition, attempts to nucleate silver nanoparticles by using 
the free protein as template did not lead to the formation of 
silver nanoparticles. Instead, inhomogeneous silver clusters 
were obtained with this synthetic approach (see Figure SI.6 in 
ESI). This fact highlights the need to use the mesoporous silica 
nanosystem functionalized with -COOH groups and decorated 
with a protein as a platform for the nucleation and synthesis of 
silver nanoparticles, as well as a platform for the vectorization 
of those nanoparticles, in the case of the transferrin protein.
In vitro cell studies
Evaluation of the cellular uptake in HepG2 and MC3T3-E1 cell lines
The enhanced cellular uptake of MSNs materials functionalized 
with Tf protein as targeting agents was assessed in a first step 
in two cell lines. HepG2, hepatocarcinoma cells, and MC3T3-
E1, osteoblast-like cells, were selected due to their clear 
different expression of transferrin receptor (TfR)52,53. This 
receptor resides in the external cell membrane and cycles in 
acid endosomes within the cell in a clatrin-dependent way to 
finally release iron and return to the cell membrane.34,35 Cells 
were incubated with 100 g/mL of the bare MSNs and protein 
decorated MSNs for 24 h. Analysis by flow cytometry was used 
to evaluate the degree of materials internalization by 
quantifying the intensity of the living cells that exhibited green 
fluorescence.
As shown in Figure 4, functionalization with Tf (MSNs-Tf) 
enhances the uptake of materials in HepG2 cells when 
compared with the bare MSNs and BSA functionalized MSNs 
(MSNs-BSA), then supporting the transferrin receptor (TfR) 
mediated cellular uptake.54
Figure 4. Cellular uptake of MSNs materials evaluated on HepG2 and MC3T3 cells 
exposed to 100 g/mL of MSNs, MSNs-BSA and MSNs-Tf for 24 h. Statistical 
significance: ***p < 0.001. 
In addition, internalization of MSNs-Tf in MC3T3-E1 cells was 
significantly lower as compared to HepG2 cells. This is 
consistent with the fact that HepG2 overexpressed TfR while 
MC3T3-E1 cells have low TfR expression. Thus, demonstrating 
the selective internalization of MSNs-Tf towards cancer cells 
overexpressing TfR. On the other hand, the slightly higher 
uptake of BSA functionalized materials compared with the 
bare MSNs in both cells lines, may be ascribed to a better 
dispersion of the nanosystems in the cell culture media due to 
the higher stabilization once MSNs are externally 
functionalized with the proteins, as reflected by the decrease 
of the maximum of the hydrodynamic size distribution (Table 
3).
Cell viability
Once tested the efficacy of the targeting, we evaluated the 
toxicity of the nanosystems containing silver nanoparticles 
(MSNs-Protein-AgNPs) in comparison with the bare MSNs and 
protein functionalized MSNs (MSNs-Protein). This study was 
carried out by evaluating the viability of cells exposed to 
different concentrations of materials at different times (24, 48 
and 72 h) (Figure 5).  When HepG2 cells were exposed to 
different concentrations of bare MSNs or MSNs functionalized 
with BSA or Tf proteins (MSNs-Protein), the viability at every 
time assayed was sustained without relevant changes, 
especially for the shortest times. However, cells treated with 
silver nanoparticles supported on MSNs-Tf (MSNs-Tf-AgNPs) 
showed a significant concentration-dependent reduction in 
viability when compared to the other tested materials (Figure 
5). Indeed, MSNs-Tf-AgNPs caused cell death to a greater 
extent than the analogous material decorated with BSA 
(MSNs-BSA-AgNPs). Bearing in mind that EDX analyses of both 
materials showed similar Si/Ag ratios, this fact is explained by 
the increased cellular uptake of materials when using 
transferrin as targeting ligand as compared to the material 
decorated with BSA, which is in agreement with the results of 
the internalization assay (Figure 4).
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Furthermore, when the viability of cells exposed to MSNs-Tf-
AgNPs is compared to the viability of cells exposed to the 
same material but without AgNPs (MSNs-Tf), a significant 
difference is evident for all the times assayed, especially at the 
higher concentrations tested. This fact confirms that the 
decrease in cell viability observed is provoked by the effect of 
AgNPs selectively transported inside the cells and can not be 
due to the nanocarrier used.
Figure 5. Cell viability of HepG2 cells exposed to different concentrations (10, 50, 100 
g/mL) of MSNs, MSNs-BSA, MSNs-Tf, MSNs-BSA-AgNPs and MSNs-Tf-AgNPs for 24 
(A), 48 (B) and 72 (C) hours (n=5). Data were analyzed by ANOVA followed by 
Bonferroni´s multiple-comparison test. ***p < 0.001 versus MSNs-Tf. #p < 0.05. ##p < 
0.01 ###p < 0.001 versus MSNs-BSA-AgNPs.
To confirm that the nucleation of AgNPs onto MSNs-Tf 
material does not affect the enhanced uptake of these 
materials, another internalization assay was carried out, 
comparing bare MSNs and MSNs-Tf-AgNPs (see Figure SI.7 in 
ESI). The uptake of bare MSNs was negligible while for MSNs-
Tf-AgNPs was significantly higher, supporting that the 
nucleation of AgNPs on transferring decorated MSNs does not 
provoke alterations in the receptor mediated internalization 
process.
Cell death
In order to evaluate whether or not the decreased observed in 
cell viability is consequence of MSNs-Tf-AgNPs-induced cell 
death, and to confirm that such effect is exclusively due to the 
released of Ag+ from the AgNPs, we evaluated the percentage 
of dead cells after exposure for 24 h to different 
concentrations of MSNs-Tf-AgNPs (10, 50 and 100 g/mL) as 
compared to the same material but without AgNPs (MSNs-Tf). 
The results (Figure 6) demonstrated that at all the tested 
concentrations, the percentage of dead cells was significantly 
higher in cells exposed to MSNs-Tf-AgNPs as compared to cells 
exposed to MSNs-Tf; thus, sustaining the cytotoxic role of 
AgNPs in the proposed nanosystem. 
Figure 6. Percentage of HepG2 dead cells after exposure for 24h to different 
concentrations of MSNs-Tf-AgNPs and MSNs-Tf (10, 50 and 100 g/mL). Statistical 
significance: ***p < 0.001. 
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Figure 7. TEM images of ultrathin sections of HepG2 cells exposed to MSNs-Tf-AgNPs. Control cells (A), HepG2 cells exposed to 25 g/mL for 24 h (B and C) and 50 g/mL for 48 h 
(D and E) of MSNs-Tf-AgNPs. EDX analysis of treated cells (F). Arrows indicate the localization of MSNs.
MSNs intracellular localization assay by TEM
To better examine the effect of AgNPs carried inside the cells, 
transmission electron microscopy (TEM) analysis of cell 
sections was used to obtain a deeper insight into the 
internalization and localization of MSNs-Tf-AgNPs in exposed 
HepG2 cells. Transmission electron micrographs of ultrathin 
sections of HepG2 cells exposed to 25 and 50 g/mL of MSNs-
Tf-AgNPs are shown in Figure 7 and Figure SI.9 in ESI. 
Differences between control cells (Figure 7A) and cells treated 
with the nanosystem (Figure 7B-7E) can be observed. While 
control (untreated) cells show no abnormalities, cells treated 
with the nanosystem exhibit large endosomes with engulfed 
nanoparticles and thus, increased degree of vacuolization. This 
effect is in accordance with the previous observed greater 
degree of internalization and reduction of cell viability as the 
nanosystem concentration and exposure times increase (See 
Figure 5 and Figures SI.7 and SI.8 in ESI).
The nanosystems were mainly located in lysosomes (Figure 7 B 
and C) due to the transferrin receptor (TfR) mediated cellular 
uptake mechanism proposed for their cell internalization as 
well as because this nanosystem was not provided with a rapid 
endosomal escape mechanism.55,56 Moreover, considering the 
size of the nanosystem MSNs could not penetrate the nuclear 
membrane (Figure 7E).57 In addition, the action of lysosomal 
proteases are likely to degrade the Tf proteins anchored on 
the external surface of the nanosystem, and therefore both 
AgNPs and MSNs would be losing their protective coating.58,59 
However, AgNPs were not observed inside the cells, neither 
free nor supported on the nanocarrier, so dissolution of the 
metal nanoparticles must have been produced. This fact can 
be explained with the “lysosome-enhanced Trojan horse 
effect” mechanism,60 in which metallic nanoparticles 
internalized by active endocytosis mechanisms can release 
toxic ions due to the degradation of nanoparticles promoted 
by the acidic conditions of the lysosomal environment (pH 4.5-
5.0). As reported in previous studies about toxicity of silver 
nanoparticles, one of the chemical reactions that may be 
implicated in this process also involves the reaction with 
reactive oxygen species (ROS) that are also caused by the 
presence of silver nanoparticles and silver ions, i.e., 2Ag + H2O2 
+ 2H+  →  2Ag+ + 2H2O (Ec0 = 0.98 V). §,61-63 For these reasons, 
we can hypothesized that the toxic effects of silver 
nanoparticles are based on the metal ions (Ag+) released as 
effectors of the activation cascades responsible for damage of 
the mitochondrial membranes, disturbances of the redox state 
and increased ROS production, apoptosis, cell cycle 
deregulation, and DNA damage, among others.62 The presence 
of these silver ions inside the cells has been confirmed by 
energy-dispersive X-ray spectroscopy (EDX) analysis of cells 
exposed to the nanosystem (Figure 7F).60,64,65
On the other hand, the observed MSNs present signals of 
degradation, such as loss of their spherical shape (Figure 7E), 
as a function of the assayed time, i.e., the time elapsed within 
the lysosome. Silica can be dissolved releasing silicic acid in the 
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conditions of the lysosomal pH, although its dissolution is 
much slower than in the case of AgNPs.59,60 The EDX analysis 
also confirms that the nanoparticles found inside the 
lysosomes contain mainly Si in their composition.
Quantitative proteomics
To gain a deeper insight in the molecular mechanisms involved 
in the interaction of the developed nanosystem with HepG2 
cells, a SILAC experiment was carried out to evaluate the 
differential nuclear protein expression after MSNs-Tf-AgNPs 
exposure (Figure SI.10.A and B in ESI).  A total of 822 proteins 
were identified by mass spectrometry analysis with at least 
one unique peptide and a false discovery rate of 0.12%, 
estimated from the number of hits against reverse or 
randomized sequence (decoy database)/total hits ratio at p > 
0.01. However, only 451 proteins passed the selected criteria 
for protein quantitation (at least two unique peptides). From 
the quantified proteins, those with a SILAC ration (RSILAC) 
higher than 1.5 or below 1.5 were considered significantly 
deregulated. According to these criteria, 15 proteins were 
found up-regulated and 17 were inhibited after MSNs-Tf-
AgNPs exposure (Table 5). As for the SILAC ratio distribution, 
most of the quantified proteins were within a SILAC ratio close 
to 1, as expected for a 1:1 mixture (Figure SI.10.C). The 
molecular and cellular functions of the altered proteins were 
classified using the Gene Ontology (GO) database.
Cell cycle and cellular proliferation. Most of the proteins 
found de-regulated upon MSNs-Tf-AgNPs exposure are 
involved in processes related to cell proliferation and cell 
cycle. The protein GNL3 is related with the regulation of 
cellular growth and proliferation through the control of the 
tumor suppressor p53.66 Overexpression of GNL3 (RSILAC = 2.58) 
impairs cell cycle progression, thus precluding cell 
proliferation67 and inducing apoptosis.68 On another hand, 
overexpression of TRIP12 (RSILAC = 1.62) produces inhibition of 
USP7, which is an ubiquitin specific processing protease whose 
depletion induce cell cycle arrest at the S phase.69 The 
inhibition of a big part of the proteins found altered in the 
study also has effects on cell proliferation. Different studies 
carried out in hepatocarcinoma cells such as Huh-7 or HepG2 
(cells employed in our work) have shown that an inhibition of 
SHMT2 (RSILAC = 2.26) or RFC3 (RSILAC = 1.91), is translated 
into an inhibition of cell proliferation and tumorigenicity70 by 
stabilization of p21, p53 and p57, and the inhibition of the 
cyclin A. All these effects induce cell cycle arrest on the S 
phase,71 which is consistent with the overexpression of TRIP12 
commented above and the inhibition of NUP62 (RSILAC = 1.50) 
and RPL34 (RSILAC = 1.68), as it has been observed in ovarian 
and lung cancer cells.72,73 Other proteins found downregulated 
after exposure to MSNs-Tf-AgNPs that are also involved in 
alteration of the cell cycle by stabilization of p53 are RPS23 
(RSILAC = 1.65) and RPS26 (RSILAC = 1.37). In addition, the 
inhibition of RPS26 and RPS6 (RSILAC = 1.37) induce 
downregulation of RPL11 (RSILAC = 1.22), another key protein 
involved in cell cycle and progression.74 That is also the case of 
KPNA2 (RSILAC = -1.56), which promotes the cell cycle transition 
G1/S by increasing c-Myc, Akt and cyclin D1 expression, and 
inhibiting FOXO3a, p21 and p27. This protein has been found 
to be overexpressed in numerous cancer types. In fact, when 
this protein is downregulated, as it has been observed in our 
study (RSILAC = 1.56), inhibition of the tumorigenicity and 
proliferation of cells occur by decreasing c-Myc and increasing 
FOXO3a activity.75 This result is in agreement with the 
downregulation of IGF2BP1 (RSILAC = 1.77) found in our SILAC 
experiment, which also affects cell proliferation and induce 
apoptosis76 through c-Myc and Ki-67, as it has been observed 
in hepatocellular carcinoma and melanoma cells.77 Finally, 
downregulation of CHERP (RSILAC = 2.85) that impairs Ca2+ 
mobility through the stimulation of the T lymphocyte receptor 
by stimulating the G-protein-linked thrombin receptor,78 and 
DDX3X (RSILAC = 1.77), which prevents the transition G1/S,79 
has also been linked with decreased cyclin D1 expression and 
cell proliferation. In the case of CHERP, its downregulation has 
also been demonstrated to induce cellular apoptosis through 
the ATF4/CHOP/DR5 pathway, producing inhibition of the 
AKT/mTOR signaling pathway;80 while inhibition of DDX3X also 
produces depletion of Rac-1 and -catenin, which enhance 
cellular adhesion, compromise cellular mobility, and therefore 
decrease the metastatic charge, as shown in breast and lung 
cancer.79
The presence of MSNs-Tf-AgNPs inside lysosomes, detected by 
TEM (Figure 7) could also be related with the mechanisms 
involved in the inhibition of cell proliferation. In fact, several 
proteins related to lysosomes were found altered in the 
proteomic experiment. That is the case of KPNA2, PSIP1 or 
SEPT9. Downregulation of SEPT9 (RSILAC = -1.59), is particularly 
significant because SEPT9 belongs to a family of proteins called 
septins, that are modulators of endo-lysosomal membrane 
trafficking.81 Specifically, SEPT9 participates indirectly in the 
degradation of tyrosine kinase receptors, such as EGFR. 
Diesenberg et al.82 demonstrated that depletion of SEPT9 
resulted in a significant reduction of the expression of EGFR in 
the cell membrane.83 This receptor is related to the activation 
of different signalling pathways including those involved in cell 
proliferation, regulation of apoptosis and tumorigenesis. These 
results help to explain the mechanisms associated to the 
observed antiproliferative potential of the proposed 
nanosystem. 
DNA damage repair and stress response. If most proteins 
found inhibited in our SILAC experiments are related to cell 
cycle regulation and cell proliferation, most of the proteins 
found up-regulated after exposure to the MSNs-Tf-AgNPs 
nanosystem, are involved in DNA repair and stress response 
mechanisms. SMCHD1, which takes part in gene silencing and 
DNA damage related processes, and usually appears down-
regulated in hepatic cancer.84 The overexpression and 
accumulation of this protein in areas where DNA damage has 
been produced indicates a high degree of DNA repair.85 A 
similar role is played by HNRNPUL2 and RAD21, which also 
accumulate in DNA damaged areas, where they promote 
effective DNA repair.86,87 In our study, all three proteins were 
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found overexpressed after MSNs-Tf-AgNPs exposure: SMCHD1 
(RSILAC = 2.66), HNRNPUL2 (RSILAC = 1.60) and RAD21 (RSILAC = 
1.57). These results suggest the activation of the DNA repair 
machinery after exposing HepG2 cells to the designed MSNs-
Tf-AgNPs nanosystem. In addition to DNA damage response, 
there are some proteins that appear overexpressed as a 
response to stress generated in the cells. One of these proteins 
is ENO1 which is overexpressed and impaired in tumor cells 
contributing to the Warburg effect.88 In addition, ENO1 has 
also been demonstrated to be upregulated in hypoxic 
conditions in cancer cells. Considering this, ENO1 acts as a 
stress response protein allowing the cells to overcome these 
situations through the activation of the anaerobic 
metabolism.89 ENO1 was found to be overexpressed in our 
experiment (RSILAC = 1.68), which is consistent to the existence 
of hypoxic conditions generated by oxygen reactive species 
(ROS) induced by AgNPs. Similarly, the protein PSIP1 
(LEDGF/p75), which is also involved in oxidative stress,90 was 
also found overexpressed (RSILAC = 1.93), which support the 
hypothesis that the designed nanosystem is inducing oxidative 
stress in cancer cells.
Table 5. Deregulated proteins obtained in the SILAC study after HepG2 cells exposure to the MSNs-Tf-AgNPs nanosystem.
gi number Protein name Common name R
SILAC
RSD
SILAC
194394237 Villin-1 [Homo sapiens] VIL1 -3.34 13.73
119226260 Calcium homeostasis endoplasmic reticulum protein [Homo 
sapiens]
CHERP -2.85 4.69
261862348 Serine hydroxymethyltransferase, mitochondrial isoform 3 [Homo 
sapiens]
SHMT2 -2.26 17.30
4506489 Replication factor C subunit 3 isoform 1 [Homo sapiens] RFC3 -1.91 18.71
4557469 AP-2 complex subunit beta isoform b [Homo sapiens] AP2B1 -1.90 8.30
56237027 Insulin-like growth factor 2 mRNA-binding protein 1 isoform 1 
[Homo sapiens]
IGF2BP1 -1.78 9.63
301171467 ATP-dependent RNA helicase DDX3X isoform 2 [Homo sapiens] DDX3X -1.77 19.17
98986457 Host cell factor 1 [Homo sapiens] HCFC1 -1.67 11.74
4506701 40S ribosomal protein S23 [Homo sapiens] RPS23 -1.65 10.25
11321585 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 
[Homo sapiens]
GNB1 -1.61 14.35
5453740 Myosin regulatory light chain 12A [Homo sapiens] MYL12A -1.61 18.81
116256489 Septin-9 isoform c [Homo sapiens] SEPT9 -1.59 18.39
4505917 Exosome component 10 isoform 2 [Homo sapiens] EXOSC10 -1.59 11.80
15011936 40S ribosomal protein S26 [Homo sapiens] RPS26 -1.56 3.97
4504897 Importin subunit alpha-2 [Homo sapiens] KPNA2 -1.56 19.75
189491630 Upstream-binding protein 1 isoform LBP-1b [Homo sapiens] UBP1 -1.54 19.34
24497603 Nuclear pore glycoprotein p62 [Homo sapiens] NUP62 -1.50 19.29
10800130 Histone H2A type 1-D [Homo sapiens] HIST1H2AD 1.50 10.32
5453994 Double-strand-break repair protein rad21 homolog [Homo 
sapiens]
RAD21 1.57 19.53
118601081 Heterogeneous nuclear ribonucleoprotein U-like protein 2 [Homo 
sapiens]
HNRNPUL2 1.60 4.51
4505343 Nuclear cap-binding protein subunit 1 [Homo sapiens] NCBP1 1.60 12.42
10863903 E3 ubiquitin-protein ligase TRIP12 [Homo sapiens] TRIP12 1.62 1.16
4503571 Alpha-enolase isoform 1 [Homo sapiens] ENO1 1.68 2.87
89179321 Protein unc-45 homolog A isoform 3 [Homo sapiens] UNC45A 1.68 11.73
283436222 ATPase family AAA domain-containing protein 3A isoform 2 
[Homo sapiens]
ATAD3A 1.71 6.41
4503529 Eukaryotic initiation factor 4A-I isoform 1 [Homo sapiens] EIF4A1 1.71 19.97
4506675 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 
subunit 1 precursor [Homo sapiens]
RPN1 1.78 0.75
19923653 PC4 and SFRS1-interacting protein isoform 1 [Homo sapiens] PSIP1 1.93 16.95
101943240 General transcription factor 3C polypeptide 1 [Homo sapiens] GTF3C1 2.12 15.46
14589866 Aspartyl/asparaginyl beta-hydroxylase isoform a [Homo sapiens] ASPH 2.21 14.65
45593130 Guanine nucleotide-binding protein-like 3 isoform 1 [Homo 
sapiens]
GNL3 2.58 8.80
148839305 Structural maintenance of chromosomes flexible hinge domain-
containing protein 1 [Homo sapiens]
SMCHD1 2.66 7.37
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Figure 8.  A) Levels of mRNA of the different altered genes: CHERP, SHMT2, RFC3 and 
DDX3X. Statistical significance when compared to the control: **p<0.01 and 
***p<0.001.  B) Levels of mRNA of the proteins that form the G1/S transition 
regulatory complex (Cyclin E and Cdk2). Statistical significance when compared to the 
control: *p<0.05 and ***p<0.001.  C) Levels of mRNA of SMCHD1 and PSIP1. Statistical 
significance when compared to the control: **p<0.01 and ***p<0.001.
Validation of the results obtained by SILAC by gene 
expression analysis. In order to validate the results obtained 
by quantitative proteomics, gene expression analysis was 
carried out for selected mRNAs. We first evaluated the 
expression of 4 mRNA related to 4 proteins that were found 
significantly altered in our SILAC experiment: CHERP, SHMT2, 
RFC3 and DDX3X. We selected these mRNAs since they are 
well-known targets for cancer therapy. Thus, it seemed crucial 
to validate if the designed nanosystem affects such relevant 
targets. The results obtained (Figure 8A) confirm the inhibition 
of the 4 tested transcripts after exposure to the MSNs-Tf-
AgNPs nanosystem (Table 5). As commented before, this 
inhibition implies a reduction in cell proliferation. In particular, 
it has been shown that the inhibition of any of these proteins, 
which have been studied in numerous types of cancer, leads to 
a failure in the synthesis and replication of DNA inducing a cell 
cycle arrest at the G1/S transition.91 This cell cycle checkpoint 
is regulated by the action of a complex formed by Cyclin E and 
Cdk2. For this reason, and in order to obtain a deeper 
knowledge about the effect of the designed nanosystem at the 
molecular level, the mRNA expression of Cyclin E and Cdk2 
were also evaluated. The results obtained (Figure 8B) also 
showed the inhibition of these transcripts upon exposure to 
the MSNs-Tf-AgNPs nanosystem, and thus demonstrate its 
effect on arresting the cell cycle at the G1/S transition. Finally, 
the mRNA expression levels of two of the most upregulated 
proteins (SMCHD1 and PSIP1) found in the SILAC experiment 
were also evaluated. The results demonstrated an inhibition in 
the expression of the two transcripts (Figure 8C), which is not 
consistent with the results obtained for the corresponding 
proteins (Table 5). However, it is important to consider that 
while the protein expression was evaluated only considering 
the nuclear fraction, the mRNA expression analysis was carried 
out with total lysates. Therefore, these results suggest that the 
increase protein expression observed by SILAC for SMCHD1 
and PSIP1, might be caused by an accumulation of these 
proteins in the nucleus, rather than by a general 
overexpression in the cell. These results are consistent with 
the fact that both, SMCHD1 and PSIP1 tend to accumulate in 
DNA damage sites to facilitate the repair of double-strand 
breaks,85,92 which support the previous finding related to the 
DNA damage induced by the MSNs-Tf-AgNPs nanosystem.
Conclusions
In conclusion, a novel nanosystem able to transport AgNPs 
selectively to cancer cells has been developed. In a first stage, 
mesoporous silica nanoparticles externally decorated with 
carboxylic acid groups and proteins such as BSA and Tf act as 
effective platform for the nucleation of AgNPs homogeneous 
in size of approximately 15 nm. After physico-chemical 
characterization, in vitro assays in hepatocarcinoma cells 
(HepG2) and osteoblast-like cells (MC3T3-E1) demonstrate 
that only the nanosystem functionalized with Tf is able to 
selectively transport the AgNPs inside the cells overexpressing 
transferrin receptors (HepG2), therefore causing a reduction in 
cell viability and an increased in cell death. Due to the receptor 
mediated endocytic mechanism for the internalization of the 
nanosystem, the transported AgNPs dissolve in toxic Ag+ ions 
during the retention time within the lysosomes, following the 
“lysosome-enhanced Trojan horse effect”. Therefore, this 
novel nanomaterial is able to deliver AgNPs specifically to 
cancer cells overexpressing TfR, affecting key proteins and 
transcripts involved in cell cycle regulation, cell proliferation 
and DNA damage, as it has been demonstrated by quantitative 
proteomics and validated by qPCR. Thus, the present 
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nanosystem offers the possibility of a targeted therapy using 
reduced doses of silver nanoparticles as cytotoxic agent. 
Furthermore, the silica matrix of the presented nanosystem 
could be used to host another drug in the pore network which 
would enhance its cytotoxic properties against cancer cells, 
transforming this material into a multidrug delivery device for 
a combined therapy. Due to the selectivity and effectiveness of 
the designed nanosystem in reducing cancer cell proliferation 
and in targeting relevant cancer-related proteins and 
transcripts, on-going work is aiming at exploring the suitability 
of this hybrid nanosystem in clinical applications.
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